Vygon North America, a leading medical device company and wholly-owned subsidiary of Vygon SA, with globally recognized products in critical care, neonatology/pediatrics, vascular access, anesthesia, and respiratory, today announced the appointment of Kim Schelble as senior vice president of North American sales & marketing.

In this key commercial role, Kim will serve on the subsidiary’s executive leadership team and will have responsibilities to grow and expand the reach and brand promise to over 220 children’s hospitals, 5,500 hospitals, 1,000 integrated delivery networks and 600 group purchasing organizations within the U.S. and Canada.

“We are excited to welcome Kim to our leadership team,” said Peter Ciriello, CEO Vygon North America. “Kim brings eighteen consecutive years of medical device experience, has launched over 35 new Class II and Class III PMA medical device products, and has eminence in vascular access, neonatal/pediatrics and peripheral vascular. I look forward to his strategic leadership and commitment towards executing on our long-range strategic plan.”

Kim previously served as vice president and general manager vascular access at Smiths Medical ASD, where he oversaw the largest business unit with $430 million in annual sales. Kim led the Vascular Access Business Unit leadership team and was head of global marketing. More recently, he worked as vice president and managing director at Poly Medicure Ltd., establishing the company’s North American subsidiary, overseeing sales and marketing efforts for a wide range of vascular, respiratory, and critical care products in both human health and animal health, gaining FDA 510(k) clearance and signing up globally recognized distributors.

Kim has worked at well-known global strategic medical device companies including Medtronic Inc. Spine & Biologics, Medtronic plc and Covidien plc. Peripheral vascular as well as novel private equity-backed start-ups including DFine Inc. and Cerapedics Inc. in various director and vice president commercial roles.

“I am very excited to join Peter and the Vygon North America Leadership team, to grow and deliver value to U.S. and Canadian hospitals and integrated delivery networks with our leading neonatal, pediatrics, vascular access, and anesthesia/respiratory products,” said Kim Schelble. “I have been impressed with the talented and highly motivated team that Peter has built and look forward to providing meaningful solutions to improve the delivery of medicine and critical care to some of the most vulnerable and deserving patients with our hospital and IDN partners.”

Kim has his Master of Business Administration (full time MBA) from the UCLA Anderson School of Management in Finance & Marketing and carries a Bachelor of Science in Commerce (B.S.C) with a concentration in Marketing from Santa Clara University in California.

Kim began his career at Deloitte & Touche as an analyst and later an associate in the firm’s IPO Center of Excellence and Venture Capital Services Group and has carried on that tradition helping medical device companies with capital raising and access to capital within the medical device sector.

About Vygon

Vygon SA (Vygon) is a medical specialty company that designs, manufactures, and markets single use medical and surgical products. The company offers products in various specialties and therapeutic areas such as pediatrics, neonatology, support for post-operative pain relief, anesthesia, emergency and intensive care units, vascular access, surgery, and home care, among others. The company manufactures its products at plants in Europe, Mauritius, Colombia, and the U.S. and offers its products to healthcare professionals in hospitals and to independent practitioners. The company markets products directly and through a network of distributors across the Americas, Asia, Europe, the Middle East, and Africa. Vygon is headquartered in Ecouen, France.

For more information on Vygon’s worldwide corporation, please visit www.vygon.com

For more information on Vygon North America, please visit www.vygonusa.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240521909829/en/